Non-surgical reduction of septal myocardial mass in a patient with hypertrophic obstructive cardiomyopathy.

  title={Non-surgical reduction of septal myocardial mass in a patient with hypertrophic obstructive cardiomyopathy.},
  author={Y. Fusegawa and S. Abe and M. Sakakibara and S. Handa},
  journal={Internal medicine},
  volume={38 7},
Non-surgical reduction of septal myocardial mass was performed with success in a 48-year-old male with hypertrophic obstructive cardiomyopathy. Angioplasty balloon inflated in the first septal branch of the left anterior descending artery dramatically reduced the pressure gradient across the outflow tract of the left ventricle. Following injections of absolute alcohol into the artery with the balloon kept inflated induced a small septal myocardial infarction. By hemodynamic evaluation, the peak… Expand


Transluminal percutaneous septal myocardial ablation in a patient with hypertrophic obstructive cardiomyopathy.
A case of severe HOCM that was dramatically improved by this non-surgical treatment and would seem to to be a promising technique for reducing pressure gradient in symptomatic patients with H OCM. Expand
Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy: outcome in the first series of patients.
Nonsurgical septal reduction significantly reduces left ventricular outflow tract obstruction and improves symptoms in some patients with hypertrophic obstructive cardiomyopathy, and the technique may provide an alternative to surgical myomectomy in selected patients. Expand
Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients.
PTSMA of HOCM is a promising nonsurgical technique for septal myocardial reduction, with a consecutive reduction in LVOT gradient, according to clinical and echocardiographic follow-up. Expand
Induced septal infarction: a new therapeutic strategy for hypertrophic obstructive cardiomyopathy.
In this issue of Circulation, another seemingly paradoxical therapy is reported: the induction of a localized myocardial infarction, which appears to be beneficial in patients with this condition. Expand
Idiopathic Hypertrophic Subaortic Stenosis: I. A Description of the Disease Based Upon an Analysis of 64 Patients
The finding of a murmur before the age of 1 year in 9 of the 64 patients, and the reports of IHSS in a stillborn baby and in several infants, as well as the association of IhSS with congenital cardiac malformations, all support the concept that the disease may, at least in some instances, be congenital. Expand
Septal myotomy-myomectomy versus mitral valve replacement in hypertrophic cardiomyopathy. Ten-year follow-up in 185 patients.
A comparison of preoperative and postoperative hemodynamic findings revealed a significant reduction in left ventricular outflow gradient at rest in septal myotomy-myomectomy and mitral valve replacement patients with hypertrophic cardiomyopathy. Expand
Idiopathic Hypertrophic Subaortic Stenosis: II. Operative Treatment and the Results of Pre‐ and Postoperative Hemodynamic Evaluations
In 10 of 64 patients with IHSS, operations designed to relieve obstruction were performed, and one patient, in whom operative pressure measurements indicated satisfactory relief of obstruction, died suddenly on the eighth postoperative day, apparently from arrhythmia. Expand
DDD pacing in hypertrophic cardiomyopathy: a multicentre clinical experience.
Although a correlation was shown between acute and chronic left ventricular outflow tract gradient reduction, there was no correlation between magnitude of gradient reduction and functional improvement, and no appreciable change in pharmacological burden. Expand
Ventricular enlargement and remodeling following acute myocardial infarction: mechanisms and management.
Rational management to prevent severe myocardial ischemia includes restoration of the patency of the occluded vessel and ventricular unloading. Expand
Amelioration of Angina Pectoris in Idiopathic Hypertrophic Subaortic Stenosis with Beta‐Adrenergic Blockade
The mechanism by which propranolol is efficacious in this disease is probably related to the diminution of myocardial O2 requirements resulting from the reduction of wall tension, velocity of contraction, and heart rate induced by beta-adrenergic receptor blockade. Expand